Molecular biomarker analysis and survival in patients (pts) with advanced urothelial cancer (UC) previously treated with chemotherapy.

Bernadett Szabados,Marlon C. Rebelatto,Craig Barker,Alvin Milner,Arthur Lewis,Michael Stokes,Magda Zajac,Thomas Powles,Norah J. Shire

Molecular biomarker analysis and survival in patients (pts) with advanced urothelial cancer (UC) previously treated with chemotherapy.

2019

Bernadett Szabados
Marlon C. Rebelatto
Craig Barker
Alvin Milner
Arthur Lewis
Michael Stokes
Magda Zajac
Thomas Powles
Norah J. Shire

4529Background: The biomarkers PD-L1, FOXP3, and CD8 have been explored in pts with advanced UC who progressed after platinum-based chemotherapy (CTx). However, their relevance earlier in the disea...

Keywords:

Oncology
Pathology
Biomarker Analysis
Cancer
Medicine
Chemotherapy
Internal medicine
molecular biomarker
in patient
urothelial cancer
previously treated
Biomarker (medicine)
FOXP3

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations